share_log

Senti Biosciences | 4: Statement of changes in beneficial ownership of securities-Director Farokhzad Omid

Senti Biosciences | 4: Statement of changes in beneficial ownership of securities-Director Farokhzad Omid

Senti Biosciences | 4：持股變動聲明-董事 Farokhzad Omid
美股SEC公告 ·  07/13 04:22
牛牛AI助理已提取核心訊息
On July 10, 2024, Farokhzad Omid engaged in a transaction involving Senti Biosciences, Inc. (SNTI). The specific details of the transaction, such as the action type, status, number of shares, nature of shares, transaction price, and the total value of shares, were not disclosed in the announcement. The relationship of Farokhzad Omid to the issuer was also not specified. Without these details, the impact of this transaction on Farokhzad Omid's holdings and on Senti Biosciences remains unclear to investors.
On July 10, 2024, Farokhzad Omid engaged in a transaction involving Senti Biosciences, Inc. (SNTI). The specific details of the transaction, such as the action type, status, number of shares, nature of shares, transaction price, and the total value of shares, were not disclosed in the announcement. The relationship of Farokhzad Omid to the issuer was also not specified. Without these details, the impact of this transaction on Farokhzad Omid's holdings and on Senti Biosciences remains unclear to investors.
2024年7月10日，Farokhzad Omid參與了涉及Senti Biosciences，Inc.（SNTI）的交易。在公告中未披露交易的具體細節，如行動類型，狀態，股數，股票性質，交易價格以及股票總價值。Farokhzad Omid與發行人的關係也未指明。缺乏這些細節，投資者無法確定此交易對Farokhzad Omid的持股和對Senti Biosciences的影響。
2024年7月10日，Farokhzad Omid參與了涉及Senti Biosciences，Inc.（SNTI）的交易。在公告中未披露交易的具體細節，如行動類型，狀態，股數，股票性質，交易價格以及股票總價值。Farokhzad Omid與發行人的關係也未指明。缺乏這些細節，投資者無法確定此交易對Farokhzad Omid的持股和對Senti Biosciences的影響。
有用
沒用

該公告為獨立文件：

獨立文件1  查看翻譯

譯文內容由第三人軟體翻譯。


牛牛AI助手部分由第三方人工智慧模型基於資訊內容自動產生，只对除中国内地以外的地区提供。


以上內容僅用作資訊或教育之目的，不構成與富途相關的任何投資建議。富途竭力但無法保證上述全部內容的真實性、準確性和原創性。